Global Critical Care Diagnostics Market 2018-2022
About Critical Care Diagnostics
Critical Care Diagnostics are used to treat patients with life-threatening conditions. Critical care diagnostic products are used to treat patients in emergency care units, critical care units and ICUs.
Technavio’s analysts forecast Global Critical Care Diagnostics market to grow at a CAGR of 6.35% from 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the Global Critical Care Diagnostics market for the period 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report - Global Critical Care Diagnostics Market 2018-2022
Technavio recognizes the following companies as the key players in the Global Critical Care Diagnostics market for 2018-2022: Abbott, BD, bioMérieux, Danaher, F. Hoffmann-La Roche, Siemens Healthcare
Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is the adoption of next-generation technology.”
According to the report, one driver in the market is the growing focus on diagnosis of chronic conditions and infectious diseases.
Further, the report states that one challenge in the market is the lack of skilled professionals.
F. Hoffmann-La Roche
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook